Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INSMED Inc | 100,973 | reported | 13 May 2026 | tx 79+1,785,891−239,133 |
| Definium Therapeutics, Inc. | 50,000 | reported | 29 Jan 2026 | tx 1+50,000 |
| Landos Biopharma, Inc. | 0 | reported | 23 May 2024 | tx 6+72,000−7,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 May 2026 | SALE | INSMED Inc | 5,837 | 116.18 USD | |
| 03 Feb 2026 | SALE | INSMED Inc | 791 | 156.17 USD | |
| 29 Jan 2026 | GRANT_AWARD | Definium Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 06 Jan 2026 | SALE | INSMED Inc | 1,429 | 173.33 USD | |
| 08 Jan 2026 | SALE | INSMED Inc | 2,059 | 174.17 USD | |
| 07 Jan 2026 | SALE | INSMED Inc | 802 | 175.07 USD | |
| 02 Jan 2026 | GRANT_AWARD | INSMED Inc | 5,998 | — | |
| 02 Jan 2026 | GRANT_AWARD | INSMED Inc | 31,280 | 0.00 USD | deriv |
| 19 Aug 2025 | SALE | INSMED Inc | 20,193 | 127.42 USD | |
| 19 Aug 2025 | SALE | INSMED Inc | 4,807 | 128.27 USD | |
| 16 Jun 2025 | SALE | INSMED Inc | 4,186 | 99.32 USD | |
| 16 Jun 2025 | SALE | INSMED Inc | 6,500 | 98.50 USD | |
| 03 Jun 2025 | SALE | INSMED Inc | 1,860 | 71.50 USD | |
| 15 May 2025 | GRANT_AWARD | INSMED Inc | 6,508 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | INSMED Inc | 31,610 | 0.00 USD | deriv |
| 14 May 2025 | SALE | INSMED Inc | 1,925 | 65.61 USD | |
| 13 May 2025 | SALE | INSMED Inc | 7,482 | 67.81 USD | |
| 10 Feb 2025 | SALE | INSMED Inc | 26,141 | 79.33 USD | |
| 10 Feb 2025 | SALE | INSMED Inc | 11,053 | 77.02 USD | |
| 10 Feb 2025 | SALE | INSMED Inc | 5,781 | 78.36 USD | |
| 07 Feb 2025 | SALE | INSMED Inc | 100 | 79.57 USD | |
| 05 Feb 2025 | GRANT_AWARD | INSMED Inc | 88,680 | 0.00 USD | |
| 06 Feb 2025 | SALE | INSMED Inc | 45,605 | 80.90 USD | |
| 14 Jan 2025 | SALE | INSMED Inc | 1,457 | 68.72 USD | |
| 10 Jan 2025 | SALE | INSMED Inc | 3,604 | 63.62 USD |